Jefferies analyst Dennis Ding downgraded Amicus Therapeutics (NASDAQ: FOLD) from Buy to Hold with a price target of $14.50 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE